Kalbe Farma (KLBF), the largest healthcare company listed on Indonesia Stock Exchange (IDX), is among few blue chip stocks which only lost 2% year-to-date. It posted revenues growth of 4.4% only in the first quarter, significantly weaker than Kimia Farma, Merck, and Indofarma. To subscribe please click here